Published in J Hypertens on September 01, 2009
Establishing International Blood Pressure References Among Nonoverweight Children and Adolescents Aged 6 to 17 Years. Circulation (2015) 1.54
Hypertension in late adolescence and cardiovascular mortality in midlife: a cohort study of 2.3 million 16- to 19-year-old examinees. Pediatr Nephrol (2015) 1.42
Should mean arterial pressure be included in the definition of ambulatory hypertension in children? Pediatr Nephrol (2013) 1.41
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis (2013) 1.08
Hypertensive crisis in children. Pediatr Nephrol (2011) 1.07
Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol (2010) 1.03
Ambulatory blood pressure monitoring in children: imperfect yet essential. Pediatr Nephrol (2011) 1.00
Ethnicity and cardiovascular risk factors: evaluation of 40,921 normal-weight, overweight or obese children and adolescents living in Central Europe. Int J Obes (Lond) (2014) 0.95
Strengths and limitations of current pediatric blood pressure nomograms: a global overview with a special emphasis on regional differences in neonates and infants. Hypertens Res (2015) 0.91
The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2013) 0.90
Posterior reversible encephalopathy syndrome revealing renal artery stenosis in a child. BMJ Case Rep (2013) 0.88
The first Iranian recommendations on prevention, evaluation and management of high blood pressure. ARYA Atheroscler (2012) 0.86
Pediatric hypertension: An update on a burning problem. World J Cardiol (2014) 0.86
Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe. Clin Drug Investig (2016) 0.85
Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)? Eur Arch Psychiatry Clin Neurosci (2014) 0.84
Blood pressure control and left ventricular mass in children with chronic kidney disease. Clin J Am Soc Nephrol (2010) 0.83
Focus on prevention, diagnosis and treatment of hypertension in children and adolescents. Ital J Pediatr (2013) 0.83
Validation of the BPLab(®) 24-hour blood pressure monitoring system in a pediatric population according to the 1993 British Hypertension Society protocol. Med Devices (Auckl) (2015) 0.83
A smartphone intervention for adolescent obesity: study protocol for a randomised controlled non-inferiority trial. Trials (2014) 0.83
Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations. Pediatr Nephrol (2011) 0.83
Correlation of blood pressure, obesity, and adherence to the Mediterranean diet with indices of arterial stiffness in children. Eur J Pediatr (2012) 0.83
Improvement of left ventricular mass with antihypertensive therapy in children with hypertension. Pediatr Nephrol (2010) 0.83
The Prevalence of Pre-hypertension in Children with Type 1 Diabetes Mellitus. Int J Prev Med (2014) 0.82
The Impact of Kidney Development on the Life Course: A Consensus Document for Action. Nephron (2017) 0.82
Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy. Pediatr Nephrol (2012) 0.82
Assessment and management of obesity in childhood and adolescence. Nat Rev Gastroenterol Hepatol (2011) 0.82
Prehypertension and cardiovascular risk factors in children and adolescents participating in the community-based prevention education program family heart study. Int J Prev Med (2014) 0.82
Rational use of antihypertensive medications in children. Pediatr Nephrol (2013) 0.82
Educational paper: Progression in chronic kidney disease and prevention strategies. Eur J Pediatr (2012) 0.82
Carotid intima-media thickness and elastic properties of aortas in normotensive children of hypertensive parents. Hypertens Res (2015) 0.81
Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension. Pediatr Nephrol (2011) 0.81
Prehypertension and Hypertension among Schoolchildren in Brazzaville, Congo. Int J Hypertens (2014) 0.80
Blood pressure variability, prehypertension, and hypertension in adolescents. Adolesc Health Med Ther (2012) 0.80
Different diagnostic criteria significantly affect the rates of hypertension in 18-year-old high school students. Arch Med Sci (2010) 0.80
Prematurity-related hypertension in children and adolescents. Int J Pediatr (2012) 0.79
Adolescent hypertension identified with correct cuff and its cardiovascular and gestational problems after 29 years. Rev Lat Am Enfermagem (2014) 0.79
Hypertension in the teenager. Pediatr Clin North Am (2013) 0.79
Performance of Eleven Simplified Methods for the Identification of Elevated Blood Pressure in Children and Adolescents. Hypertension (2016) 0.79
Evidence-based guidelines for the management of hypertension in children with chronic kidney disease. Pediatr Nephrol (2015) 0.79
Definition of pediatric hypertension: are blood pressure measurements on three separate occasions necessary? Hypertens Res (2017) 0.79
Screening blood pressure measurement in children: are we saving lives? Pediatr Nephrol (2013) 0.79
Renal outcome in children born preterm with neonatal acute renal failure: IRENEO-a prospective controlled study. Pediatr Nephrol (2016) 0.78
Metabolic syndrome in children with chronic kidney disease and after renal transplantation. Pediatr Nephrol (2013) 0.78
Simple references for managing arterial hypertension in children with kidney disease. J Hypertens (2010) 0.78
Monogenic forms of hypertension. Eur J Pediatr (2011) 0.78
User-friendly tools to identify elevated blood pressure in children. Paediatr Child Health (2013) 0.78
Microalbuminuria in children with primary and white-coat hypertension. Pediatr Nephrol (2011) 0.78
Management of proteinuria in the transplanted patient. Pediatr Nephrol (2014) 0.78
Blood pressure tables for Chinese adolescents: justification for incorporation of important influencing factors of height, age and sex in the tables. BMC Pediatr (2014) 0.78
Prevalence of hypertension and associated factors in ahvaz school age children in 2013. Int J Community Based Nurs Midwifery (2014) 0.77
Risk Factors in Adolescent Hypertension. Glob Pediatr Health (2016) 0.77
Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences. Curr Hypertens Rep (2013) 0.77
Olmesartan medoxomil for the treatment of hypertension in children and adolescents. Vasc Health Risk Manag (2011) 0.77
Benefit of BP Measurement in Pediatric ED Patients. ISRN Nurs (2012) 0.77
Therapeutic options for the treatment of hypertension in children and adolescents. Clin Med Insights Circ Respir Pulm Med (2012) 0.76
Early vascular phenotypes in the genesis of hypertension. Pediatr Nephrol (2010) 0.76
What is the optimal first-line agent in children requiring antihypertensive medication? Curr Hypertens Rep (2012) 0.76
Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease. Pediatr Nephrol (2012) 0.76
Chapter 8: Future directions and controversies. Kidney Int Suppl (2011) (2012) 0.75
Chapter 6: Blood pressure management in children with CKD ND. Kidney Int Suppl (2011) (2012) 0.75
The effects of celecoxib or naproxen on blood pressure in pediatric patients with juvenile idiopathic arthritis. Clin Med Insights Pediatr (2015) 0.75
Screening, diagnosis and treatment of hypertension in obese children: an international policy comparison. J Nephrol (2016) 0.75
Can Pediatric Hypertension Criteria Be Simplified? A Prediction Analysis of Subclinical Cardiovascular Outcomes From the Bogalusa Heart Study. Hypertension (2017) 0.75
Non-communicable diseases among children in Ghana: health and social concerns of parent/caregivers. Afr Health Sci (2016) 0.75
Familial aggregation and childhood blood pressure. Curr Hypertens Rep (2015) 0.75
Clinical features and mortality in Chinese with lupus nephritis and neuropsychiatric lupus: A 124-patient study. J Res Med Sci (2014) 0.75
How important it is to determine the blood pressure in paediatric patients? BMJ Case Rep (2012) 0.75
Nocturnal blood pressure non-dipping is not associated with increased left ventricular mass index in hypertensive children without end-stage renal failure. Eur J Pediatr (2016) 0.75
Hypertension in chronic kidney disease: role of ambulatory blood pressure monitoring. Prog Pediatr Cardiol (2015) 0.75
Pulsatile and Steady-State Pressure Trends in Children: Is the Future Now?: Comment on the Paper by Zachariah and Kovacikova [Pulse 2014;2:57-62]. Pulse (Basel) (2015) 0.75
The association between blood pressure and grip strength in adolescents: does body mass index matter? Hypertens Res (2016) 0.75
Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults. Eur J Clin Pharmacol (2016) 0.75
Angiotensin-Converting Enzyme Inhibitor Initiation and Dose Uptitration in Children With Cardiovascular Disease: A Retrospective Review of Standard Clinical Practice and a Prospective Randomized Clinical Trial. J Am Heart Assoc (2016) 0.75
Cardiovascular changes during chronic hypertensive states. Pediatr Nephrol (2013) 0.75
Hypertension in romanian children and adolescents: a cross-sectional survey. Maedica (Buchar) (2013) 0.75
Prospective analysis of utility and feasibility of ambulatory blood pressure monitoring service in a pediatric nephrology set up. Indian J Nephrol (2013) 0.75
Treatment strategies to prevent renal damage in hypertensive children. Curr Hypertens Rep (2014) 0.75
Hypovitaminosis D and nocturnal hypertension in obese children: an interesting link. J Hum Hypertens (2013) 0.75
Clinical and biological markers of premature aging after autologous SCT in childhood cancer. Bone Marrow Transplant (2017) 0.75
(1)H-MRS measured ectopic fat in liver and muscle is associated with the metabolic syndrome in Danish girls but not in boys with overweight and obesity. Obes Sci Pract (2016) 0.75
The Challenges of Arterial Hypertension. Front Cardiovasc Med (2015) 0.75
Blood Pressure Profile in the 7th and 11th Year of Life in Children Born Prematurely. Iran J Pediatr (2016) 0.75
Associations of the eNOS G894T gene polymorphism with target organ damage in children with newly diagnosed primary hypertension. Pediatr Nephrol (2015) 0.75
Cardiovascular Risk Factors in 7-13 Years Old Children from Vojvodina (Serbia). J Med Biochem (2016) 0.75
Tailored Assays for Pharmacokinetic and Pharmacodynamic Investigations of Aliskiren and Enalapril in Children: An Application in Serum, Urine, and Saliva. J Pediatr Pharmacol Ther (2016) 0.75
Fatal cerebral haemorrhage in a hypertensive seven-year-old boy. JRSM Open (2016) 0.75
Reductions in blood pressure during a community-based overweight and obesity treatment in children and adolescents with prehypertension and hypertension. J Hum Hypertens (2017) 0.75
To screen or not to screen: for high blood pressure. Pediatr Nephrol (2017) 0.75
Recommended standards for assessing blood pressure in human research where blood pressure or hypertension is a major focus. J Hum Hypertens (2017) 0.75
New Markers of Inflammation and Tubular Damage in Children with Chronic Kidney Disease. Dis Markers (2017) 0.75
Validation of the custo screen pediatric blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010. Eur J Pediatr (2017) 0.75
Hypertension in pediatric patients with chronic kidney disease: management challenges. Int J Nephrol Renovasc Dis (2017) 0.75
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
Point: cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol (1985) (2006) 11.52
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet (2004) 11.13
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA (2011) 8.83
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet (2012) 6.78
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72
Strict blood-pressure control and progression of renal failure in children. N Engl J Med (2009) 5.71
Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int (2005) 5.49
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med (2006) 5.18
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11
Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med (2009) 4.96
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens (2003) 4.91
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation (2005) 4.69
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet (2010) 3.75
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA (2003) 3.71
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens (2011) 3.50
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med (2011) 3.28
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens (2005) 3.27
Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens (2002) 3.21
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
The Virtual Family--development of surface-based anatomical models of two adults and two children for dosimetric simulations. Phys Med Biol (2009) 3.05
Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension (2007) 2.94
Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie. Pediatr Nephrol (2008) 2.92
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet (2013) 2.91
Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89
Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol (2006) 2.89
Theory, evidence and Intervention Mapping to improve behavior nutrition and physical activity interventions. Int J Behav Nutr Phys Act (2005) 2.83
Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol (2012) 2.83
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet (2004) 2.78
Ambulatory arterial stiffness index does not accurately assess arterial stiffness. J Hypertens (2012) 2.71
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet (2004) 2.67
MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med (2011) 2.65
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension (2006) 2.65
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64